Projects

RNDr. Monika Baráthová, PhD.

National

Current
  • Orchestration of tumor and immune microenvironment in renal cell carcinoma and significance of tumor organoids in predicting therapy response
    Program: SRDA
    Duration: 1. 7. 2024 – 30. 6. 2028
  • Regulation of hypoxic signalling in renal carcinoma with focus on the role of carbonic anhydrase IX in the tumor microenvironment
    Program: VEGA
    Duration: 1. 1. 2024 – 31. 12. 2027
Finished
  • Effect of combinaion therapy with carnosine on tumorigenesis in colorectal carcinoma models
    Program: VEGA
    Duration: 1. 1. 2020 – 31. 12. 2023
  • Clinical evaluation of prognostic and predictive value of tissue and serum Carbonic Anhydrase IX in breast cancer
    Program: Other projects
    Duration: 1. 11. 2019 – 31. 12. 2022
  • Impact of comorbidity therapy on tumorigenesis and a role of the tumor microenvironment in this process
    Program: SRDA
    Duration: 1. 7. 2017 – 31. 12. 2021
  • Drug repurposing as a novel approach to therapy of colorectal carcinoma: molecular mechanisms and potential applications
    Program: VEGA
    Duration: 1. 1. 2016 – 31. 12. 2019
  • Molecular pathways influenced by CA IX in hypoxic cancer cell lines
    Program: VEGA
    Duration: 1. 1. 2015 – 31. 12. 2018
  • Biological properties and immunotherapeutic potential of the monoclonal antibodies specific for the tumor-associated protein CA IX
    Program: VEGA
    Duration: 1. 1. 2009 – 31. 12. 2011
  • Molecular mechanisms of regulation and function of endosialin, a hypoxia-inducible marker of tumor angiogenesis
    Program: VEGA
    Duration: 1. 1. 2009 – 31. 12. 2011
  • Significance of the carbonic anhydrase IX as a non-invasive prognostic indicator and a molecular target in renal cell carcinoma
    Program: VEGA
    Duration: 1. 1. 2009 – 31. 12. 2011
Employees